Jau‐Tsuen Kao - Concepedia

Author

Jau‐Tsuen Kao

National Taiwan University ORCID

Also Known As

J Kao, J T Kao, J. Kao, J.-T. Kao, J.‐T. Kao, Jau Tsuen Kao, Jau-Tsuen Kao, Jau‐Tsuen Kao

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Taiwan University National Taiwan University Hospital Chang Gung University National Yang Ming Chiao Tung University National Cheng Kung University

About

Jau‐Tsuen Kao is an author at National Taiwan University specializing in medicine, public health, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	842
2	Public Health	12	13	617
3	Engineering	2	2	29
4	Health Sciences	2	2	47
5	Natural Sciences	1	1	72

Jau‐Tsuen Kao

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Population genetic screening efficiently identifies carriers of autosomal dominant diseases Joseph J. Grzymski, Gai Elhanan, Joel A. Morales‐Rosado, Nature Medicine Genetic AnalysisDisease SusceptibilityGenetic TestingMedicineGenetics	2020	203
A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia Jau‐Tsuen Kao Human Molecular Genetics	2003	166
Urine sediment examination: A comparison of automated urinalysis systems and manual microscopy Tzu-I Chien, Jau‐Tsuen Kao, Hui-Lan Liu, Clinica Chimica Acta Urogenital RadiologyAutomated Urinalysis SystemsUrological ResearchUrologyMicroscopy	2007	109
Regression-Based Association Analysis with Clustered Haplotypes through Use of Genotypes Jung‐Ying Tzeng, Chih‐Hao Wang, Jau‐Tsuen Kao, The American Journal of Human Genetics Genome-wide Association StudyGenetic AnalysisHaplotype DeterminationGenetic DeterminantGenotype-phenotype Association	2006	80
The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis Chia‐Lun Chao, Hui-Hsin Tsai, Chi‐Ming Lee, Atherosclerosis Metabolic SyndromeGraded EffectVascular DiseaseCoronary AtherosclerosisCardiovascular Disease	1999	74
Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Evan A. Stein, Linda P. DiPersio, A J Pesce, Clinical Chemistry ImmunologyHyperlipidemiaBioanalysisApolipoprotein AiiImmunochemistry	1986	72
The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population Jau‐Tsuen Kao, Keh‐Sung Tsai, Chih‐Jen Chang, Atherosclerosis Apolipoprotein E PolymorphismMetabolic SyndromeLipid DisorderCardiovascular DiseaseGenetics	1995	64
Early serum <scp>HBsAg</scp> level as a strong predictor of sustained response to peginterferon alfa‐2a in <scp>HBeAg</scp>‐negative chronic hepatitis B C.‐Y. Peng, Hsueh‐Chou Lai, Yufen Li, Alimentary Pharmacology & Therapeutics	2012	40
APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese Kuo‐Liong Chien, Woei-horng Fang, Hui-Chin Wen, Clinica Chimica Acta Metabolic SyndromeLipid DisorderCardiovascular DiseaseDiabetesHyperlipidemia	2007	36
Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP Tzu-I Chien, Hui-hou Chen, Jau‐Tsuen Kao Clinica Chimica Acta Abbott AxsymRoche Elecsys 2010Measurement	2006	36

Page 1